RAMP TROPONIN I

The definitive biomarker for acute myocardial infarction (AMI)

The Challenge

WHEN EARLY RECOGNITION OF AMI IS KEY

  • Estimated 17.9 million people died from cardiovascular diseases in 2016, representing 31% of all global deaths
  • There are 32.4 million myocardial infarctions and strokes worldwide every year
  • The sensitivity of ECGs for MI is poor (28%-54%)
  • One-thirds of MI patients do not present with chest pain but instead with non-specific symptoms such as fatigue, nausea, dizziness
, RAMP TROPONIN I, Response Biomedical

The Solution

, RAMP TROPONIN I, Response Biomedical

TEST PRINCIPLES

  • Quantitative fluorescent immunoassay
  • Sample: 75 µL EDTA whole blood
  • Time to Result: ~19 minutes
  • Single use test cartridge with barcode defines lot specific calibration
  • Proprietary RAMP® buffer enhances performance
  • A calibrated transfer device is provided with every kit
  • RAMP ratio corrects for sources of analytical variability A calibrated transfer device is provided with every kit
  • RAMP Troponin I (Tni)

    • Cardiac Troponin is the gold standard test for myocardial infarction and is usually the first test ordered for patients with chest pain
    • Measurements of cardiac troponin I can improve diagnosis and treatment of myocardial infarction (MI)
    • With RAMP Troponin I, healthcare professionals can obtain a quantitative measurement of cardiac troponin I from 75uL of blood without the need for centrifugation
    • RAMP tests are individual, single-use quantitative tests that provide rapid, accurate, lab quality results within minutes

    Additional Information

    , RAMP TROPONIN I, Response Biomedical

    data

    24 Hour Technical Support Available for all RAMP Customers

    Contact Our Specialists

    For Any Inquiries

    QUICK QUOTE

    Share on linkedin
    Share on facebook
    Share on google
    Share on twitter
    Share on email

    Share this page

    Share on linkedin
    LinkedIn
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on email
    Email